Bernard Coche‐Dequeant

Papers

Total Citations

H-Index

About

Bernard Coche‑Dequeant is a radiation oncologist whose research centers on stereotactic radiotherapy for intracranial tumors, with a particular focus on meningiomas. His major contribution lies in demonstrating the efficacy and safety of hypofractionated stereotactic radiotherapy (hFSRT) for patients with intracranial meningiomas, a treatment approach that delivers higher doses per fraction over fewer sessions. In his most cited work (2018, 25 citations), he evaluated 126 patients with 136 meningiomas treated with robotic hFSRT, providing critical evidence that this regimen achieves excellent local control while maintaining a favorable toxicity profile. This study has helped establish hFSRT as a viable alternative to conventional fractionation, offering patients shorter treatment courses without compromising outcomes. Coche‑Dequeant’s work is particularly impactful for clinicians managing skull‑base and complex meningiomas, where precise dose delivery is paramount. His research contributes to the growing body of evidence supporting hypofractionation in intracranial radiotherapy, influencing treatment guidelines and patient counseling. Through careful dosimetric analysis and long‑term follow‑up, he has advanced the field’s understanding of optimal fractionation schedules, making him a respected voice in stereotactic radiosurgery and radiation oncology.